Skip to content
  • EN
info@priavoid.com
+49 211 942 522 98
Priavoid
  • About us
  • Platform
  • Pipeline
  • Partnering
  • Media
  • Contact

Press Release

  • News, Press Release

    Priavoid Presents Preclinical Proof-of-Concept for PRI-101 Demonstrating α-synuclein Aggregate Disassembly at AD/PD™ 2026

    Read more

  • News, Press Release

    Priavoid Presents Initial Phase 2 Data Suggesting Favorable Safety Profile for Alzheimer’s Candidate PRI-002 at AD/PD™ 2026

    Read more

  • News, Press Release

    Priavoid to Present Initial Phase 2 Safety Data for Alzheimer‘s and Preclinical PoC for Parkinson‘s Programs at AD/PD™ 2026

    Read more

  • News, Press Release

    Priavoid appoints CSO and CMO

    Read more

  • News, Press Release

    PRImus-AD: Recruitment for Phase II clinical trial of Alzheimer’s drug PRI-002 successfully completed

    Read more

  • News, Press Release

    Priavoid receives funding from the Alzheimer’s Association and the Rainwater Charitable Foundation to further develop its tau program

    Read more

  • News, Press Release

    New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study

    Read more

  • News, Press Release

    Priavoid and Research Center Jülich receive funding from The Michael J. Fox Foundation

    Read more

  • News, Press Release

    Priavoid closes financing round

    Read more

  • News, Press Release

    Alzheimer´s Research: Important Milestone for PRI-002

    Read more

  • News, Press Release

    Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

    Read more
PRIAVOID
  • About us
  • Platform
  • Pipeline
  • Partnering
  • Media
  • Imprint
  • Privacy Policy
  • Cookie Policy
Contact us

©

2026

Priavoid GmbH. All rights reserved.

  • EN
Page load link
Priavoid
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}